News Release

Promising blood cancer researchers in Europe to receive award to study in US

Grant and Award Announcement

American Society of Hematology

(WASHINGTON, February 27, 2007) – The first recipients have been selected for a new international scholarship opportunity, sponsored by the European Hematology Association (EHA) and the American Society of Hematology (ASH), for scientists in training or the early phase of their careers. The EHA-ASH International Fellowship Award not only provides researchers from North America and Europe with the chance to pursue their studies in a different environment, but is intended to build stronger ties between these scientific communities.

The 2007 awardees, Giovanni Roti, MD, and Marta Crespo, PhD, will each be provided with $75,000 to fund their research, plus additional travel stipends to attend the EHA and ASH annual meetings to hear current scientific developments relevant to their work.

“As a European scientist, I have always admired the American academic model and aspired to train in this environment,” stated Dr. Roti. “This opportunity will broaden my exposure to new genomic models of scientific discovery and deepen my knowledge about a field of research not accessible in my current laboratory in Italy.”

Dr. Roti, a resident at the Italian Perugia University, will pursue his work at the Dana-Farber Cancer Institute in Boston on the modulation of a gene called Notch1. Dr. Crespo, from the Hospital Clinic of Barcelona, will develop her research project on specific protein interactions in chronic lymphocytic leukemia at the Institute for Cancer Genetics at Columbia University in New York.

###

For more information about the EHA-ASH International Fellowship Award, visit http://www.hematology.org/education/awards/ifa.cfm.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.